Labo Euromedis (FRA:61R) Cash per Share: €5.84 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61R Labo Euromedis FRA:61R
61 GF Score
Price €4.92
GF Value €4.47
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis Cash per Share?

Labo Euromedis FRA:61R 61 Cash per Share is €5.84 as of Dec. 2025. GuruFocus rates FRA:61R with a GF Score™ of 61/100 and a GF Value™ of €4.47. The stock has 6 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Labo Euromedis's Cash per Share for the quarter that ended in Dec. 2025 was €5.84.

Labo Euromedis  (FRA:61R) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Labo Euromedis Cash per Share Related Terms

Labo Euromedis Cash per Share Historical Data

* Premium members only.

The historical data trend for Labo Euromedis's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis Cash per Share Chart

Labo Euromedis Annual Data
Trend Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.66 9.17 6.61 5.34 5.84

Labo Euromedis Semi-Annual Data
Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.61 6.55 5.34 5.66 5.84
FRA:61R
61GF Score
Labo Euromedis FRA:61R
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labo Euromedis Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Labo Euromedis's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=16.672/2.86
=5.84

Labo Euromedis's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=16.672/2.86
=5.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of €5.84 mean?
Labo Euromedis (FRA:61R) has a Cash per Share of €5.84 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Labo Euromedis and its competitors.
Is Labo Euromedis' Cash per Share too high?
Labo Euromedis' current Cash per Share is €5.84. Overall, Labo Euromedis has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Cash per Share compare to MCK and COR?
Labo Euromedis' Cash per Share of €5.84 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Distribution company?
A good Cash per Share depends on the Medical Distribution industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Labo Euromedis and its competitors. Labo Euromedis's current Cash per Share is €5.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Labo Euromedis (FRA:61R) has a current Cash per Share of €5.84. The stock's GF Value™ is €4.47, compared to a current price of €4.92 — trading 10.1% above its estimated fair value. The current Cash per Share is €5.84. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Labo Euromedis (FRA:61R), the current Cash per Share is €5.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labo Euromedis (FRA:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.92 is trading 10.1% above its estimated GF Value™ of €4.47.

Key valuation signals for FRA:61R:

  • Cash per Share: €5.84
  • GF Value™: €4.47 vs. price of €4.92 (10.1% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score

Get the complete analysis for FRA:61R

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.92
Price
€4.47
GF Value